Company clear when big sales push will come Q1 2025 this is a strategic approach no point fielding staff with autumn and winter ahead best to wait until Spring/Summer. In the meantime they will as you say get their ducks inline.
"A broader digital launch of Sofdra will follow in Q4 CY 2024 and Botanix expects to receive first prescriptions from these sales in Q4 CY2024. Botanix expects to field a sales force in Q1 2025, targeting high decile prescribers of therapeutics for hyperhidrosis across the USA."
BOT - Anything but charting, page-9616
-
- There are more pages in this discussion • 1,598 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add BOT (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
36.0¢ |
Change
-0.010(2.70%) |
Mkt cap ! $654.2M | |||
| Open | High | Low | Value | Volume |
| 37.0¢ | 37.0¢ | 34.5¢ | $2.959M | 8.301M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 5 | 74186 | 36.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 36.5¢ | 422090 | 8 |
View Market Depth
| Last trade - 16.10pm 15/10/2024 (20 minute delay) ? |
| BOT (ASX) Chart |